newsfilter
← Latest News
GlobeNewswire·

Belite Bio to Host Webcast on November 10, 2025, to Discuss Third Quarter 2025 Financial Results

SAN DIEGO, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ:BLTE), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have